{
    "title": "109_hr3423",
    "content": "The Act may be cited as the \"Medical Device User Fee Stabilization Act of 2005\" and includes amendments to the Federal Food, Drug, and Cosmetic Act. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. The Medical Device User Fee Stabilization Act of 2005 amends the Federal Food, Drug, and Cosmetic Act by adjusting device user fees and annual fee setting procedures. In general, fees for the next fiscal year will be published in the Federal Register under subsection (a). The fees for fiscal year 2007 will be based on a premarket application fee of $281,600. The Secretary may use unobligated carryover balances from fees collected in previous fiscal years for fiscal years 2006 and 2007 to ensure sufficient fee revenues are available, maintaining unobligated carryover balances of at least 1 month of operating reserves for the first month of fiscal year 2008. Notification to Congress is required 14 days before the funds are used. \"In subsection (d), the term 'small business' is defined as an entity with $30,000,000 or less in gross receipts or sales in its most recent Federal income tax return.\" In subsection (d), a small business is defined as an entity with $30,000,000 or less in gross receipts or sales in its most recent Federal income tax return. Additionally, in subsection (g)(1), the threshold is increased from $30,000,000 to $100,000,000. For fiscal year 2005, the Secretary must meet performance goals if the appropriated amount is equal to or greater than $205,720,000 multiplied by the adjustment factor. For fiscal year 2005, if the appropriated amount is more than 1 percent less than the specified amount, certain conditions apply. For fiscal year 2005, the appropriated amount must be more than 1 percent less than the specified amount, with changes made to the text regarding the years. In subsection (h)(3), changes are made to subparagraphs (C), (D), and (E) for fiscal years 2006 and 2007. Additionally, \"subsection (c)(5)\" is replaced with \"subsection (c)(1)\" throughout the text. The annual reports under the Medical Device User Fee and Modernization Act of 2002 are amended to include additional information for fiscal years 2006 and 2007, such as details on different types of applications, fees paid by businesses with varying sales, and notifications. The Medical Device User Fee and Modernization Act of 2002 is amended to include details on fees paid by businesses with varying sales, categorized in intervals, and a certification by the Secretary regarding appropriations for FDA expenses. The Medical Device User Fee and Modernization Act of 2002 is amended to include details on fees paid by businesses with varying sales, categorized in intervals, and a certification by the Secretary regarding appropriations for FDA expenses. Section 502(u) of the Federal Food, Drug, and Cosmetic Act is amended to require reprocessed single-use devices to prominently display the manufacturer's name, abbreviation, or symbol. The Medical Device User Fee and Modernization Act of 2002 now requires reprocessed single-use devices to display the manufacturer's name, abbreviation, or symbol prominently on the packaging or through a detachable label for patient records. The Secretary of Health and Human Services will issue guidance within 180 days to clarify these requirements. The manufacturer of the original device must display their name, abbreviation, or symbol prominently as required by the Federal Food, Drug, and Cosmetic Act. The effective date for this requirement is specified in the Medical Device User Fee and Modernization Act of 2002. The Fee Stabilization Act of 2005 specifies the effective dates for displaying the manufacturer's name, abbreviation, or symbol on medical devices. The Fee Stabilization Act of 2005 specifies the effective dates for displaying the manufacturer's name, abbreviation, or symbol on medical devices, with specific regulations for devices reprocessed and introduced in interstate commerce after the applicable effective date. The curr_chunk is about the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}